Trending...
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
MILWAUKEE, April 1, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Amdocs, Ltd. (NASDAQ: DOX). The investigation results from inaccurate statements Amdocs may have made regarding its financial results, business operations and prospects.
Click here to learn more about the investigation: https://www.ademilaw.com/case/amdocs-ltd or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
The investigation focuses on whether Amdocs properly disclosed its financial results. A March 31 report from short seller Jehoshaphat Research says that Amdocs is committing a "massive financial deception" by reporting "widely overstated profit margins." According to Jehoshaphat Research, former employees and direct competitors of Amdocs, including a former American Amdocs executive, stated that the Amdocs' "US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable."
More on Wisconsin Eagle
If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, https://www.ademilaw.com/case/amdocs-ltd
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
SOURCE Ademi LLP
Related Links
http://www.ademilaw.com
Click here to learn more about the investigation: https://www.ademilaw.com/case/amdocs-ltd or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
The investigation focuses on whether Amdocs properly disclosed its financial results. A March 31 report from short seller Jehoshaphat Research says that Amdocs is committing a "massive financial deception" by reporting "widely overstated profit margins." According to Jehoshaphat Research, former employees and direct competitors of Amdocs, including a former American Amdocs executive, stated that the Amdocs' "US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable."
More on Wisconsin Eagle
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
- Revenue Optics Names Prat Patibandla Director of Growth Marketing
- Independent Autopsies Are Changing Civil Cases: Kansas City Forensic Explains Why Families Are Seeking Second Opinions
- JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero
If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, https://www.ademilaw.com/case/amdocs-ltd
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
SOURCE Ademi LLP
Related Links
http://www.ademilaw.com
0 Comments
Latest on Wisconsin Eagle
- Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland
- Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
- Bank Statement Loans Up to $30 Million: Lendmire Announces High-Net-Worth Financing
- NYC Big Book Award Celebrates 10th Anniversary with Announcement of 2026 Winners
- Regional Magazines Shine at IRMA Awards
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
- Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- PIQSTAR Launches RECLAIM THE SCREEN, Giving College Media Programs Their Own Streaming Channel
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)